How to manage renal masses in kidney transplant recipients? A collaborative review by the EAU-YAU kidney transplantation and renal cancer working groups

Andraș, Iulia; Telecan, T.; Piana, Alberto; Boissier, R.; Hevia, V.; Prudhomme, Thomas; Bertolo, Riccardo; Carbonara, U.; Erdem, S.; Diana, Pietro; Ingels, Alexandre; Kara, O.; Marandino, L.; Marchioni, M.; Muselaers, Stijn; Pavan, N.; Pecoraro, Alessio; Roussel, E.; Crisan, N.; Territo, Angelo; Campi, Riccardo

doi:10.1016/j.acuroe.2023.04.006

Cited by 1 publication

(1 citation statement)

References 35 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Although there is still no consensus on the period between the localized tumor extirpation and transplant, we should keep in mind that the positive lymph nodes should be considered as one of the contraindications. Since patients had positive lymph nodes in previous malignancies, their 5-year disease-free survival would only range from 0% to 32% [26]. Hemodialysis was started at the 6th day after surgery Glans infection (Clavien-Dindo grade 2)…”

Section: Discussionmentioning

confidence: 99%

One-Step Robot-Assisted Complete Urinary Tract Extirpation in Man with End-Stage Renal Disease on Dialysis: The First Case Report

et al. 2023

View full text Add to dashboard Cite

Urothelial carcinoma (UC) could be observed in urinary bladder (UBUC) and upper urinary tracts (UTUC). In the National Comprehensive Cancer Network guidelines for bladder cancer, extirpative surgery is indicated in certain cases. However, some extreme cases might also need the extirpation of the majority of the urinary tract, which is called complete urinary tract extirpation (CUTE). We present a patient diagnosed with high-grade UBUC and UTUC. He underwent dialysis for end-stage renal disease (ESRD) at the same time. Considering his non-functional kidneys and removing his high-risk urothelium at the same time, we performed robot-assisted CUTE to extirpate both his upper urinary tracts, urinary bladder, and prostate. In our experience, the console time was not significantly elongated, and the perioperative course was uneventful. To our knowledge, this is the first case report adopting a robotic system in such an extreme case. We conclude that robot-assisted CUTE is worth further study regarding its oncological survival outcomes and perioperative safety in patients with ESRD on dialysis.

show abstract

Section: Discussionmentioning

confidence: 99%